Evidence map›Paper›PMID 37126389›Full record

ArticleNeurourology and urodynamics2023

Destroyed bladders: Characterization of progressive inflammatory cystitis.

Anna Faris, Giulia I Lane, Rohit Mehra, Vipulkumar Dadhania, Iryna Crescenze, J Quentin Clemens, Paholo Barboglio Romo, John Stoffel, Bahaa Malaeb, Yooni Blair and 3 more

Open access · greenAbstract read
In one paragraph

Article in Neurourology and urodynamics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Anna FarisDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-9049-1939
Giulia I LaneDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-6977-5280
Rohit MehraDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Vipulkumar DadhaniaDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Iryna CrescenzeDepartment of Urology, Ohio State University, Columbus, Ohio, USA.
J Quentin ClemensDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Paholo Barboglio RomoDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
John StoffelDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-5503-4940
Bahaa MalaebDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Yooni BlairDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Meidee GohDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Priyanka GuptaDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Anne P CameronDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0001-8414-3065
University of Michigan · USThe Ohio State University · US

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
University of Michigan UroEPI Career Development ProgramK12DK111011 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CLEMENS, J. QUENTIN, SARMA, ARUNA V · 2016 to 2025
$3.6M
Uro Translational Research and Clinical Research Training (UroTRACT)T32DK007782 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEI, JOHN T · 2000 to 2019
$2.9M
Improving urinary and sexual dysfunction after prostate surgery using shared decision makingF32DK126232 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI IPPOLITO, GIULIA MARIA ROSA · 2020 to 2021
$83k
NCATS NIH HHS UL1 TR002240NIDDK NIH HHS F32 DK126232NIDDK NIH HHS K12 DK111011NIDDK NIH HHS T32 DK007782
6 · The paper itself

Abstract

purposeWe identified a subset of patients with noninfectious cystitis who develop refractory symptoms marked by diffuse inflammatory changes, reduced bladder capacity, and vesicoureteral reflux (VUR), termed here as "progressive inflammatory cystitis" (PIC). Our objective was to describe the phenotype, disease outcomes, and pathologic findings of PIC. MATERIAL AND

methodsA single institution retrospective cohort study of patients with PIC. Patients with a history of pelvic radiation, urologic malignancy, or neurogenic bladder were excluded. We describe cohort characteristics and use bivariate analyses to compare subgroups. Kaplan-Meier methods estimate time to urinary diversion.

resultsFrom 2008 to 2020, 46 patients with PIC were identified. The median age of symptom onset was 63 years old (interquartile range [IQR]: 56, 70) and the most common presenting symptoms were urinary urgency/frequency (54%) and incontinence (48%). Urodynamics showed a median maximum bladder capacity of 80 mL (IQR: 34, 152), commonly with VUR (68%) and hydronephrosis (59%). Ultimately 36 patients (78%) underwent urinary diversion at a median of 4.5 years (IQR: 2, 6.5) after symptom onset. Significant pathologic findings include presence of ulceration (52%), acute and chronic inflammation (68%), including eosinophils (80%), lymphoid follicles (56%), and mast cells in both lamina and muscularis propria (76%).

conclusionsPIC is a newly defined entity characterized by significantly diminished bladder capacity, upper tract changes, and relatively quick progression to urinary diversion. Larger prospective cohort studies are required to further characterize this severe phenotype of chronic noninfectious cystitis, aid earlier diagnosis, and guide management decisions.

Indexed as

CystitisUrinary IncontinenceVesico-Ureteral RefluxHumansProspective StudiesRetrospective StudiesUrinary BladderCystitishydronephrosislower urinary tract symptomsurinary bladder diseasesurinary tract infectionsvesicoureteral reflux

Identifiers

PMID37126389
PMCPMC11542153
OpenAlexW4367600769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.